Evolent Health, Inc.
EVH
$2.99
-$0.07-2.29%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,956.80% | -4.86% | 69.21% | -183.39% | 1.45% |
| Total Depreciation and Amortization | 118.36% | 2.70% | -1.22% | 1,172.06% | -94.03% |
| Total Amortization of Deferred Charges | -11.74% | 36.94% | -6.40% | 3.58% | -0.93% |
| Total Other Non-Cash Items | 1,974.78% | -18.86% | -64.58% | 105.16% | 90.00% |
| Change in Net Operating Assets | 420.22% | 80.83% | -157.82% | 49.10% | -552.51% |
| Cash from Operations | 208.63% | 152.13% | -764.49% | 117.40% | -240.50% |
| Capital Expenditure | 638.88% | 85.15% | -360.70% | -609.26% | 114.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 193.40% | -- | -- | -22.99% |
| Cash from Investing | 1,037.61% | 85.52% | -362.32% | 34.31% | -1.02% |
| Total Debt Issued | -89.15% | -- | -100.00% | 277.29% | -- |
| Total Debt Repaid | 31.80% | -- | 100.00% | -11,914.74% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 99.86% | -144,696.43% | 99.39% | -1,381.61% | 55.20% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | 58.26% | -0.96% | 4.76% | 6.39% |
| Other Financing Activities | 284.04% | 68.96% | 89.69% | -196.56% | 877.43% |
| Cash from Financing | -122.49% | -368.41% | -108.28% | 11.26% | 1,176.18% |
| Foreign Exchange rate Adjustments | -11.94% | -142.17% | -460.87% | 116.91% | -338.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 207.80% | 64.99% | -200.53% | 96.17% | 601.53% |